AZ Hematology Hub

Featured Moments highlights of international experts' sessions captured in short videos.

Configure Paragraph Text Component

 

 

EHA & ASCO updates in B-Cell malignancies

Configure Image Component

Acalabrutinib and Other Novel Therapies in Mantle Cell Lymphoma

Dr. Michael Wang, United States

Configure Image Component

Continues Therapy Versus Time Limited Therapy in High-Risk CLL Patients

Dr. Wojciech Jurczak, Poland

Configure Image Component

Optimizing the Usage of BTK Inhibitors in CLL

Dr. Cyrus Khan, US

Precision approach for CLL treatment

Configure Image Component

Critical Evaluation of BTKis in CLL

Dr. George Follows, UK

Configure Image Component

Latest Updates in Management of CLL

Dr. Davide Rossi, Switzerland

Configure Image Component

How to Choose BTK Inhibitors for CLL Patients?

Dr. Krish Patel, US

CLL Management 2023 - Year in Review

Configure Image Component

Review on Time to Progression Regimen in CLL Management

Dr. George Follows, UK

Modal Window Component Section Begins
Modal Window Component Section Ends